Amgen (NASDAQ 🙂 announced Wednesday that the first quarter ended with revenue exceeding analysts’ expectations.

Amgen reported earnings per share at $4.25 for revenue $6.24B. Investing.com polled analyst to predict EPS of 4.12 on $6.11B revenue.

Amgen shares rose 10% in the first quarter, but still fell 3.83% to its 52-week peak of $258.70 on May 10, 2021. The Amgen shares are performing better than the, which has fallen 20.32% since the beginning of the year.

Amgen shares gained 0.72 percent in trading after-hours as a result of the report.

Amgen is following other top Healthcare industry earnings this month

Amgen’s announcement follows a UnitedHealth earnings beat on April 14. UnitedHealth reported EPS at $5.49 on revenues of $80.15B. Forecasts were for EPS at $5.36 on revenues of $78.73B.

J&J had beat expectations on April 19 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.

Keep up to date with all the earnings reports coming soon by visiting Investing.com’s earnings calendar